Cellectis
CLLS
#9722
Rank
S$0.13 B
Marketcap
S$1.33
Share price
-4.17%
Change (1 day)
-68.87%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: S$0.13 Billion

As of November 2026 Cellectis has a market cap of S$0.13 Billion. This makes Cellectis the world's 9722th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.13 B-78.18%
2025S$0.61 B212.93%
2024S$0.19 B-32.85%
2023S$0.29 B121.95%
2022S$0.13 B-74.67%
2021S$0.51 B-69.3%
2020S$1.68 B67.75%
2019S$1.00 B0.57%
2018S$0.99 B-25.83%
2017S$1.34 B53.83%
2016S$0.87 B-42.31%
2015S$1.51 B162.5%
2014S$0.57 B582.1%
2013S$84.83 M

End of Day market cap according to different sources

On Nov 2nd, 2026 the market cap of Cellectis was reported to be:

S$0.13 Billion
by Nasdaq info icon info icon
S$0.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
S$127.30 B 95,278.65%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
S$2.03 B 1,428.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
S$2.01 B 1,407.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
S$0.58 B 340.19%๐Ÿ‡บ๐Ÿ‡ธ USA